Detalhe da pesquisa
1.
Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer.
Gastric Cancer
; 25(5): 906-915, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35763187
2.
Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma.
Int J Cancer
; 146(5): 1445-1456, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31340061
3.
A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT).
Ther Adv Med Oncol
; 14: 17588359221109196, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35782751
4.
Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT).
Clin Cancer Res
; 27(12): 3351-3359, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33504550
5.
A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX.
Cancers (Basel)
; 13(4)2021 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33671266
6.
Development and validation of an LC-MS/MS method for simultaneous quantification of co-administered trastuzumab and pertuzumab.
MAbs
; 12(1): 1795492, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32744170
7.
Quality of Life During Palliative Systemic Therapy for Esophagogastric Cancer: Systematic Review and Meta-Analysis.
J Natl Cancer Inst
; 112(1): 12-29, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31251346
8.
Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study.
J Clin Oncol
; 38(5): 462-471, 2020 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31809243
9.
Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric Adenocarcinoma (ACTION Study).
Cancers (Basel)
; 11(6)2019 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31207904
10.
Prognostic and predictive factors for overall survival in metastatic oesophagogastric cancer: A systematic review and meta-analysis.
Eur J Cancer
; 103: 214-226, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30268922
11.
Survival differences in pediatric pulmonary arterial hypertension: clues to a better understanding of outcome and optimal treatment strategies.
J Am Coll Cardiol
; 63(20): 2159-2169, 2014 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24681143